Literature DB >> 3759759

The Astrand-Ryhming nomogram revisited.

B J Legge, E W Banister.   

Abstract

Relationships among O2 uptake (VO2), heart rate, and work rate during constant-load submaximal cycle ergometry and ramp-forced exercise to exhaustion have been studied in core groups of trained (n = 15) and untrained (n = 10), 20- to 29-yr-old males. A signal aim was to improve on the accuracy of the 1954 Astrand-Ryhming (A-R) nomogram predicting maximum aerobic power from heart rate elevation at submaximum work rates. A new nomogram has been developed based on a linear relationship, established in experimental groups, between VO2 and delta HR, the latter being defined as the elevation of exercise heart rate above that reached during zero-load pedaling at 90 rpm. The delta HR variable used in a nomogram linking it and submaximum VO2 (either derived by calculation from the concomitant steady-state work rate or measured directly from respiratory gas analysis) successfully differentiated maximum aerobic power of trained from untrained subjects in core groups whose different abilities could not otherwise be distinguished by the A-R nomogram itself. In a validation group of trained (n = 5), untrained (n = 5), and moderately trained (n = 4) 20- to 29-yr-old males, the correlation measured between VO2max values and those predicted from the new nomogram was significantly better (r = 0.98) (P less than 0.05) than predictions made from the A-R nomogram (r = 0.80).

Entities:  

Mesh:

Year:  1986        PMID: 3759759     DOI: 10.1152/jappl.1986.61.3.1203

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  10 in total

Review 1.  Evidence and possible mechanisms of altered maximum heart rate with endurance training and tapering.

Authors:  G S Zavorsky
Journal:  Sports Med       Date:  2000-01       Impact factor: 11.136

2.  Novel exercise protocol suitable for use on a treadmill or a bicycle ergometer.

Authors:  S W Davies; C A Greig
Journal:  Br Heart J       Date:  1992-05

3.  Twin-sibling study and meta-analysis on the heritability of maximal oxygen consumption.

Authors:  Nienke M Schutte; Ineke Nederend; James J Hudziak; Meike Bartels; Eco J C de Geus
Journal:  Physiol Genomics       Date:  2016-01-19       Impact factor: 3.107

4.  A controlled trial of community based coronary rehabilitation.

Authors:  S W Davies; C A Greig
Journal:  Br Heart J       Date:  1991-07

5.  Long-term effects of the RealFit intervention on body composition, aerobic fitness, and behavior.

Authors:  Nina H M Bartelink; Maria W J Jansen; Stef P J Kremers; Sandra Mulkens; Suhreta Mujakovic
Journal:  Child Obes       Date:  2014-10       Impact factor: 2.992

6.  Prediction of upper extremity peak oxygen consumption from heart rate during submaximal arm cycling in young and middle-aged adults.

Authors:  Jan Helgerud; Britt Elin Øiestad; Eivind Wang; Jan Hoff
Journal:  Eur J Appl Physiol       Date:  2019-10-04       Impact factor: 3.078

7.  A comparison of diet versus diet + exercise programs for health improvement in middle-aged overweight women.

Authors:  Gili Joseph; Rinat Arviv-Eliashiv; Riki Tesler
Journal:  Womens Health (Lond)       Date:  2020 Jan-Dec

8.  Lifestyle intervention for type 2 diabetes patients: trial protocol of The Copenhagen Type 2 Diabetes Rehabilitation Project.

Authors:  Eva S Vadstrup; Anne Frølich; Hans Perrild; Eva Borg; Michael Røder
Journal:  BMC Public Health       Date:  2009-05-29       Impact factor: 3.295

9.  The effect of an interdisciplinary rehabilitation intervention comparing HRQoL, symptom burden and physical function among patients with primary glioma: an RCT study protocol.

Authors:  Anders Hansen; Lisbeth Kirstine Rosenbek Minet; Karen Søgaard; Jens Ole Jarden
Journal:  BMJ Open       Date:  2014-10-03       Impact factor: 2.692

10.  Validity of the revised Ekblom Bak cycle ergometer test in adults.

Authors:  Frida Björkman; Elin Ekblom-Bak; Örjan Ekblom; Björn Ekblom
Journal:  Eur J Appl Physiol       Date:  2016-06-16       Impact factor: 3.078

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.